IRX14 Antibody

What is IRX14 and what is its functional role in plant cell wall biosynthesis?

Recent biochemical evidence suggests IRX14 may not function independently but as part of a multiprotein xylan synthase complex (XSC) with other proteins including IRX9 and IRX10 . Interestingly, site-directed mutagenesis studies have challenged the assumption that IRX14 has catalytic activity, suggesting it may primarily serve a structural role in facilitating xylan synthesis .

What are the most effective methods for generating IRX14-specific antibodies for plant research?

Generation of effective IRX14-specific antibodies requires careful consideration of protein structure and antigenic regions. Based on published research protocols:

• Epitope selection: Target unique regions of IRX14 that have low homology with IRX14L to prevent cross-reactivity. N-terminal regions often serve as good targets as demonstrated in customized antibody production against other plant proteins .

• Expression system: Bacterial expression systems using E. coli can produce sufficient quantities of recombinant IRX14 protein fragments for immunization. For instance, studies have successfully expressed fragments comprising 246 amino acids from the N-terminal region for raising antibodies .

• Purification strategy: Use affinity tags (His, GST) for purification of the antigen, followed by tag removal if necessary to prevent antibody generation against the tag.

• Immunization protocol: Multiple immunizations in rabbits (typically 3-4 booster injections) over 8-12 weeks yield optimal antibody titers.

• Validation methods: Always validate antibody specificity using wild-type and irx14 mutant plants to confirm absence of signal in the mutant. Western blotting and immunolocalization with appropriate controls are essential validation steps .

What phenotypic and biochemical assays effectively demonstrate IRX14 antibody specificity?

To establish IRX14 antibody specificity, researchers should employ a combination of phenotypic and biochemical approaches:

Phenotypic assays:

• Compare antibody signal in wild-type, irx14 single mutant, and irx14 irx14L double mutant plants

• Include heterozygous plants (irx14 irx14L±) that show intermediate phenotypes for gradient analysis

• Use complemented mutant lines expressing wild-type IRX14 as positive controls

Biochemical assays:

• Western blotting: The primary technique for confirming antibody specificity. IRX14 antibodies should detect a band of approximately the predicted molecular weight in wild-type samples but not in irx14 mutants .

• Immunoprecipitation: Perform pull-down assays followed by mass spectrometry to confirm captured protein identity .

• Immunolocalization: Use fluorescently-labeled secondary antibodies against IRX14 antibodies to visualize cellular localization. Compare with other cell wall markers like LM10 (anti-xylan) .

• Native gel electrophoresis: Can reveal whether the antibody recognizes IRX14 in protein complexes in addition to monomeric forms .

Proper sample preparation is critical - researchers should use detergents like n-dodecyl β-d-maltoside (DDM) at 1% (w/v) for membrane protein solubilization while maintaining protein complexes .

How can IRX14 antibodies be used to study xylan distribution in plant tissues?

IRX14 antibodies serve as valuable tools for studying xylan distribution in plant tissues through several approaches:

Immunohistochemical techniques:

• Tissue fixation: Fix plant tissues (commonly stems) in 4% paraformaldehyde in PEM buffer (50 mM PIPES, 5 mM EGTA, 5 mM MgSO₄, pH 6.9) overnight at 4°C .

• Sectioning: Embed fixed tissues in 7% agarose and prepare 60 μm thick sections using a vibratome .

• Antibody application: Incubate sections with primary IRX14 antibody (typically 1:10-1:100 dilution) followed by fluorescently-labeled secondary antibody (e.g., FITC-conjugated at 1:100 dilution) .

• Visualization: Analyze using fluorescence microscopy to detect IRX14 localization .

Complementary approaches:

• Co-labeling: Use IRX14 antibodies alongside xylan-specific antibodies like LM10 to correlate protein presence with polysaccharide deposition .

• Comparative analysis: Compare IRX14 localization in wild-type versus mutant plants with altered xylan content .

• Developmental series: Track IRX14 distribution across different developmental stages, particularly during secondary cell wall formation.

IRX14 antibodies enable visualization of the protein's subcellular localization, which appears concentrated in the Golgi apparatus when co-expressed with partner proteins IRX9 and IRX10 .

What control samples should be included when using IRX14 antibodies in experimental procedures?

Rigorous controls are essential for reliable IRX14 antibody experiments:

Genetic controls:

• Negative controls: Include irx14 knockout/null mutants to confirm antibody specificity

• Redundancy controls: Include irx14L single mutants to assess potential cross-reactivity

• Complementation controls: Use irx14 mutants complemented with wild-type IRX14 to verify signal restoration

• Varying expression levels: When possible, include plants with different IRX14 expression levels (overexpression, heterozygous) to confirm signal correlation with protein abundance

Technical controls:

• Primary antibody omission: Incubate samples with only secondary antibody to detect non-specific binding

• Peptide competition: Pre-incubate antibody with the immunizing peptide to block specific binding

• Cross-species validation: Test antibody reactivity across related plant species when appropriate

• Secondary antibody controls: Use isotype-matched irrelevant primary antibodies to detect non-specific binding

Experimental procedure controls:

• For western blots: Include loading controls and molecular weight markers

• For immunolocalization: Use known cell wall markers (e.g., LM10 for xylan) as reference points

• For co-immunoprecipitation: Include non-related antibodies for precipitation to identify non-specific interactions

How do mutations in conserved motifs of IRX14 affect its function and antibody recognition?

Mutations in conserved motifs of IRX14 can reveal critical functional domains while potentially affecting antibody recognition. Site-directed mutagenesis studies have provided significant insights:

Key functional domains and their effects when mutated:

Interestingly, research has shown that while the DxD motif (involved in substrate binding) is essential for IRX14 function, mutations in predicted catalytic residues still allowed for complementation of the irx14 mutant phenotype . This suggests IRX14 may function primarily in a structural rather than catalytic capacity.

For antibody recognition, mutations may have varying effects depending on:

• The epitope recognized by the antibody

• Whether the mutation causes conformational changes

• If the mutation affects protein stability or expression levels

Researchers should be cautious when using antibodies against mutated versions of IRX14 and always validate recognition patterns with appropriate controls .

What strategies can optimize coimmunoprecipitation experiments using IRX14 antibodies to identify interaction partners?

Optimizing coimmunoprecipitation (co-IP) with IRX14 antibodies requires specialized approaches due to the membrane-associated nature of the xylan synthesis complex:

Recommended optimization strategies:

• Membrane protein solubilization:

  • Use 1% (w/v) n-dodecyl β-d-maltoside (DDM) for gentle solubilization that preserves protein-protein interactions

  • Avoid harsh detergents like SDS that disrupt protein complexes

• Crosslinking considerations:

  • Apply reversible crosslinkers like DSP (dithiobis(succinimidyl propionate)) to stabilize transient interactions

  • Optimize crosslinking time (typically 5-30 minutes) to balance capture efficiency with background

• Antibody immobilization:

  • Pre-immobilize IRX14 antibodies on Protein A/G beads to reduce background

  • Consider oriented immobilization techniques to maximize antigen-binding capacity

• Washing conditions:

  • Use gradient washing with decreasing detergent concentrations

  • Include low concentrations of competing agents to reduce non-specific binding

• Elution strategies:

  • Compare acidic elution vs. SDS elution for maximum recovery

  • Consider on-bead digestion for subsequent mass spectrometry analysis

Research has successfully employed these approaches to demonstrate that IRX14 interacts with IRX9 and IRX10 in a multi-protein xylan synthase complex (XSC) . Mass spectrometry analysis of co-IP samples can identify tryptic peptides originating from all three IRX proteins, confirming their interaction .

Notable caution: Interaction between IRX proteins appears to be relatively weak, making detection challenging without optimization . Additionally, protein tags used for detection may interfere with interactions, so native antibody detection is preferred .

Post-translational modifications (PTMs) of IRX14 can significantly impact antibody detection and protein function. Although specific PTMs of IRX14 are not extensively characterized in the provided research, general approaches can be applied:

Potential PTMs affecting IRX14 detection:

• Glycosylation: As IRX14 localizes to the Golgi apparatus , it may undergo N-linked glycosylation that could alter antibody epitope accessibility.

• Phosphorylation: Potential phosphorylation at serine/threonine residues may regulate IRX14 activity or interactions.

• Protein complex formation: IRX14 exists in high molecular weight complexes (240-480 kDa) , which may mask antibody epitopes.

Methodological approaches to assess PTMs:

• Detection of glycosylation:

  • Treat protein samples with glycosidases (PNGase F for N-linked glycans)

  • Compare western blot mobility shifts before and after treatment

  • Use lectin blotting alongside IRX14 antibody detection

• Phosphorylation analysis:

  • Use phospho-specific antibodies if available

  • Treat samples with phosphatases and observe mobility shifts

  • Perform phosphoproteomics analysis on immunoprecipitated IRX14

• Complex formation assessment:

  • Compare native PAGE with denaturing SDS-PAGE for antibody detection

  • Use crosslinking approaches to stabilize complexes

  • Combine with mass spectrometry to identify interaction partners

• Epitope mapping:

  • Generate a panel of antibodies targeting different regions of IRX14

  • Test recognition under various conditions (native/denatured/reduced)

  • Use peptide competition assays with modified and unmodified peptides

Research has shown that detection of IRX14 in native protein gels reveals bands at similar positions to IRX9 and IRX10 (just below 242- and 480-kD markers), suggesting these proteins form heterotrimeric complexes that may affect antibody accessibility .

What approaches can differentiate between IRX14 and IRX14L using antibodies despite their high sequence similarity?

Distinguishing between the highly similar IRX14 and IRX14L proteins requires specialized antibody development and validation strategies:

Epitope selection strategies:

• Sequence divergence analysis:

  • Perform detailed sequence alignment of IRX14 and IRX14L

  • Identify regions with maximum amino acid differences

  • Focus on N-terminal or C-terminal regions which typically show higher divergence

• Custom peptide antibody development:

  • Design synthetic peptides from uniquely divergent regions

  • Generate peptide-specific antibodies with affinity purification against the target peptide

  • Cross-adsorb antibodies against the homologous peptide from the other protein

Validation approaches:

• Genetic validation panel:

  • Test antibodies against wild-type, irx14 single mutant, irx14L single mutant, and irx14 irx14L double mutant samples

  • Confirm appropriate signal patterns (i.e., IRX14-specific antibody should show signal in wild-type and irx14L but not in irx14 or double mutant)

• Expression system controls:

  • Express recombinant IRX14 and IRX14L individually in heterologous systems

  • Confirm antibody specificity via western blotting

  • Test antibodies against concentration gradients of both proteins to assess cross-reactivity thresholds

• Immunoprecipitation-mass spectrometry:

  • Perform IP with the antibody followed by mass spectrometry

  • Identify unique peptides that distinguish between IRX14 and IRX14L

  • Quantify relative abundance of each protein in the immunoprecipitate

Research has demonstrated that IRX14 and IRX14L have partially redundant functions but differ in their expression patterns and contribution to xylan synthesis . While IRX14 mutations cause irregular xylem formation, IRX14L mutations alone show no observable phenotype, suggesting IRX14 plays the predominant role in xylan biosynthesis . This functional difference provides an important context for antibody specificity validation.

Experimental Troubleshooting

Optimizing fixation and tissue preparation is critical for successful IRX14 immunolocalization in plant tissues:

Comparative assessment of fixation protocols:

• Chemical fixation options:

  • Paraformaldehyde (PFA): 4% in PEM buffer (50 mM PIPES, 5 mM EGTA, 5 mM MgSO₄, pH 6.9) overnight at 4°C preserves protein antigenicity while maintaining cellular architecture

  • Glutaraldehyde/PFA combinations: While providing better structural preservation, these may reduce antibody accessibility to IRX14

  • Ethanol-acetic acid: Less suitable for membrane proteins like IRX14 due to potential denaturation

• Tissue sectioning methods:

  • Vibratome sectioning: 60 μm thick sections from agarose-embedded tissues allow good antibody penetration while maintaining tissue integrity

  • Cryosectioning: Useful for tissues difficult to section with vibratome, but requires careful optimization of freezing conditions

  • Paraffin embedding: Generally less suitable for IRX14 due to high-temperature processing that may denature membrane proteins

• Antigen retrieval considerations:

  • Heat-mediated antigen retrieval in citrate buffer (pH 6.0) can enhance accessibility

  • Enzymatic treatments (e.g., proteinase K) at very low concentrations may improve signal but risk epitope destruction

Optimization approach:

• Test multiple fixation methods on the same tissue type

• Compare signal intensity and specificity using positive controls (wild-type) and negative controls (irx14 mutants)

• Optimize fixation time, temperature, and buffer composition

• Document effects of different permeabilization techniques

Researchers successfully localized IRX14 and related proteins using the PFA fixation protocol combined with vibratome sectioning, allowing visualization of the protein's localization to the Golgi apparatus when co-expressed with its partner proteins .

What techniques can validate that an antibody is detecting native IRX14 versus denatured protein?

Validating antibody recognition of native versus denatured IRX14 is crucial for applications like immunoprecipitation and localization studies:

Validation techniques:

• Comparative western blotting:

  • Native PAGE: Run proteins under non-denaturing conditions to preserve native conformation

  • SDS-PAGE: Run typical denaturing gels with and without reducing agents

  • Comparison: An antibody recognizing only denatured forms will show signal only in SDS-PAGE

• Immunoprecipitation analysis:

  • Perform IP under native conditions

  • Test ability to pull down known interaction partners (IRX9, IRX10)

  • A native-specific antibody will efficiently immunoprecipitate intact complexes

• Dot blot analysis:

  • Spot native protein preparations directly onto membrane

  • Compare binding efficiency to denatured samples

  • Quantify relative affinities under both conditions

• ELISA-based approaches:

  • Coat plates with native versus denatured IRX14

  • Compare antibody binding curves

  • Calculate affinity constants for each condition

• Live-cell applications:

  • Test antibody function in live-cell immunolabeling if cell-penetrating antibody formats are available

  • Compare to fixed-cell results

Research has demonstrated that native IRX14 exists in heterotrimeric complexes with IRX9 and IRX10, appearing as high molecular weight bands (240-480 kDa) on native gels . Antibodies capable of recognizing native IRX14 were able to detect these complexes and successfully immunoprecipitate interaction partners, confirming their utility for studying the protein in its native state .

How can IRX14 antibodies be employed to study protein trafficking and localization dynamics?

IRX14 antibodies can be powerful tools for investigating protein trafficking and localization dynamics in plant cells:

Advanced imaging approaches:

• Live-cell imaging with fluorescently-labeled antibody fragments:

  • Generate and validate Fab or scFv fragments from IRX14 antibodies

  • Fluorescently label fragments with bright, photostable fluorophores

  • Introduce into cells via microinjection or cell-penetrating peptide tags

  • Track movement using confocal or total internal reflection fluorescence (TIRF) microscopy

• Pulse-chase immunolabeling:

  • Apply cycloheximide to inhibit new protein synthesis

  • Perform immunolabeling at timed intervals

  • Track movement of existing IRX14 through secretory pathway

• Correlative light and electron microscopy (CLEM):

  • Perform immunofluorescence to locate IRX14

  • Process same sample for electron microscopy

  • Correlate fluorescence signal with ultrastructural features

Experimental designs for trafficking studies:

• Brefeldin A treatments:

  • Treat cells with Brefeldin A to disrupt Golgi

  • Track IRX14 redistribution using antibodies

  • Monitor recovery after washout

• Temperature blocks:

  • Use temperature shifts to block protein at specific compartments

  • Release block and track movement with timed immunolabeling

• Co-trafficking studies:

  • Double-label with IRX14 antibodies and markers for secretory compartments

  • Quantify co-localization at different time points

  • Determine sequence of localization changes

Research has shown that IRX14 localizes predominantly to the Golgi apparatus when co-expressed with partner proteins IRX9 and IRX10 . Interestingly, when expressed alone, IRX14 shows more ER-like localization, suggesting that complex formation is required for proper trafficking to the Golgi . These findings highlight the utility of IRX14 antibodies in studying protein trafficking dynamics within the secretory pathway.

What considerations are important when designing super-resolution microscopy experiments with IRX14 antibodies?

Super-resolution microscopy with IRX14 antibodies requires careful consideration of several factors to achieve optimal results:

Technical considerations by super-resolution method:

• Stimulated Emission Depletion (STED) Microscopy:

  • Select secondary antibodies conjugated to photostable dyes (e.g., STAR635P, ATTO647N)

  • Optimize depletion laser power to balance resolution and photobleaching

  • Consider sample mounting media with antifade properties specific for STED

• Stochastic Optical Reconstruction Microscopy (STORM):

  • Use antibodies conjugated to photoswitchable fluorophores (Alexa Fluor 647)

  • Optimize buffer conditions (oxygen scavenging system with thiol)

  • Determine optimal power and frequency for switching lasers

• Structured Illumination Microscopy (SIM):

  • Select bright, photostable fluorophores (Alexa Fluor 488, 568)

  • Minimize sample thickness to reduce out-of-focus light

  • Use high-precision coverslips and appropriate mounting media

Sample preparation optimization:

• Fixation protocols:

  • Use minimal fixation that preserves structure while maintaining epitope accessibility

  • Consider combining mild formaldehyde fixation with post-fixation permeabilization

• Antibody concentration:

  • Titrate antibody concentrations to achieve high signal-to-noise ratio

  • Lower concentrations than conventional microscopy may reduce background

• Multi-color considerations:

  • Select fluorophores with minimal spectral overlap

  • Include controls for chromatic aberration correction

  • Consider sequential immunolabeling for closely associated proteins

Biological applications:

Super-resolution microscopy would be particularly valuable for studying:

• The nanoscale organization of IRX14 within the Golgi apparatus

• The spatial relationship between IRX14 and its interaction partners IRX9 and IRX10

• The distribution of IRX14 relative to newly synthesized xylan

Based on research findings showing IRX14 forms complexes with IRX9 and IRX10 in the Golgi apparatus , super-resolution microscopy could help resolve whether these proteins form discrete clusters or distribute more uniformly throughout Golgi membranes, providing insights into the spatial organization of xylan biosynthesis.